Browsing: Pharma

In its new “Playing with the Heart” project, Merck is touting how high levels of…

The European Medicines Agency (EMA) has set up an advisory group aimed at boosting “confidence…

The FDA reprimanded Bayer for “attention-grabbing visuals” and “frequent scene changes” in ads for its…

Patient groups’ perceptions of drug companies with large U.S. footprints have changed over the past…

Although Teva Pharmaceutical’s multi-year growth streak showed signs of leveling off under CEO Richard Francis,…

As AstraZeneca prepares for the impact of the U.S. “most-favored nation” policy, CEO Pascal Soriot…

Three years after AbbVie lost exclusive rights to its immunology blockbuster Humira, leaving it on…

GSK’s first quarter, under CEO Luke Miels, saw its flagship shingles vaccine Shingrix set a…

Sales of the eye disease drug continue to decline as regulatory delays continue to plague…

Nearly three years after the FDA approved Pfizer’s bispecific antibody Ellexfio as a late-stage treatment…